• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,922.64 443.97
( 0.58%)
Global Indices
Nasdaq
52,316.93 113.19
(0.22%)
Dow Jones
7,516.83 55.40
(0.74%)
Hang Seng
70,577.01 514.69
(0.73%)
Nikkei 225
10,484.10 -13.02
(-0.12%)
Forex
USD-INR
94.49 0.37
(0.39%)
EUR-INR
107.78 0.64
(0.60%)
GBP-INR
125.01 0.85
(0.69%)
JPY-INR
0.58 0.00
(0.33%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
493.27
15479.98
EPS(TTM)
Face Value()
Div & Yield %
1.97
1
0.51
 

Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter
Apr 28,2026
Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales684.86579.56 18 2396.372080.29 15
OPM %11.2811.99 -11.9312.74 -
PBDT87.7765.93 33 281.64252.26 12
PBT64.2447.71 35 202.52185.19 9
NP45.9734.44 33 149.21136.38 9